Candel Therapeutics, Inc.
CADL· Nasdaq
Released Aug 5, 2022, before the open
10-Q filed Aug 5, 2022, 36 days after period end · 0000950170-22-014970
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $31.00K | $31.00K | $31.00K |
| Net Income | -$4.15M | -$17.08M | -$2.88M |
| EPS Diluted | -$0.14 | -$1.46 | -$0.25 |
Candel Therapeutics, Inc. · CIK 1841387 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.